Literature DB >> 34793711

A recurrent chromosomal inversion suffices for driving escape from oncogene-induced senescence via subTAD reorganization.

Christos P Zampetidis1, Panagiotis Galanos2, Andriani Angelopoulou1, Yajie Zhu3, Aikaterini Polyzou1, Timokratis Karamitros4, Athanassios Kotsinas1, Nefeli Lagopati1, Ioanna Mourkioti1, Reza Mirzazadeh5, Alexandros Polyzos6, Silvano Garnerone5, Athanasia Mizi3, Eduardo G Gusmao3, Konstantinos Sofiadis3, Zita Gál7, Dorthe H Larsen7, Dafni-Eleftheria Pefani8, Marco Demaria9, Aristotelis Tsirigos10, Nicola Crosetto5, Apolinar Maya-Mendoza11, Angelos Papaspyropoulos1, Konstantinos Evangelou1, Jiri Bartek12, Argyris Papantonis13, Vassilis G Gorgoulis14.   

Abstract

Oncogene-induced senescence (OIS) is an inherent and important tumor suppressor mechanism. However, if not removed timely via immune surveillance, senescent cells also have detrimental effects. Although this has mostly been attributed to the senescence-associated secretory phenotype (SASP) of these cells, we recently proposed that "escape" from the senescent state is another unfavorable outcome. The mechanism underlying this phenomenon remains elusive. Here, we exploit genomic and functional data from a prototypical human epithelial cell model carrying an inducible CDC6 oncogene to identify an early-acquired recurrent chromosomal inversion that harbors a locus encoding the circadian transcription factor BHLHE40. This inversion alone suffices for BHLHE40 activation upon CDC6 induction and driving cell cycle re-entry of senescent cells, and malignant transformation. Ectopic overexpression of BHLHE40 prevented induction of CDC6-triggered senescence. We provide strong evidence in support of replication stress-induced genomic instability being a causative factor underlying "escape" from oncogene-induced senescence.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BHLHE40; DNA damage; DNA replication; Hi-C; cancer; chromatin loop; replication stress; senescence

Mesh:

Year:  2021        PMID: 34793711     DOI: 10.1016/j.molcel.2021.10.017

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  7 in total

1.  RASSF1A disrupts the NOTCH signaling axis via SNURF/RNF4-mediated ubiquitination of HES1.

Authors:  Andriani Angelopoulou; Ioanna Mourkioti; Aikaterini Polyzou; Angelos Papaspyropoulos; Daniela Pankova; Konstantinos Toskas; Simone Lanfredini; Anastasia A Pantazaki; Nefeli Lagopati; Athanassios Kotsinas; Konstantinos Evangelou; Efstathios Chronopoulos; Eric O'Neill; Vassilis Gorgoulis
Journal:  EMBO Rep       Date:  2021-12-13       Impact factor: 9.071

2.  Escape from senescence: revisiting cancer therapeutic strategies.

Authors:  Christos P Zampetidis; Argyris Papantonis; Vassilis G Gorgoulis
Journal:  Mol Cell Oncol       Date:  2022-02-15

Review 3.  Role of Senescence in Tumorigenesis and Anticancer Therapy.

Authors:  Ewelina Stoczynska-Fidelus; Marta Węgierska; Amelia Kierasińska; Damian Ciunowicz; Piotr Rieske
Journal:  J Oncol       Date:  2022-03-18       Impact factor: 4.375

Review 4.  Interplay of Developmental Hippo-Notch Signaling Pathways with the DNA Damage Response in Prostate Cancer.

Authors:  Ioanna Mourkioti; Andriani Angelopoulou; Konstantinos Belogiannis; Nefeli Lagopati; Spyridon Potamianos; Efthymios Kyrodimos; Vassilis Gorgoulis; Angelos Papaspyropoulos
Journal:  Cells       Date:  2022-08-07       Impact factor: 7.666

Review 5.  Senescence and cancer - role and therapeutic opportunities.

Authors:  Clemens A Schmitt; Boshi Wang; Marco Demaria
Journal:  Nat Rev Clin Oncol       Date:  2022-08-31       Impact factor: 65.011

Review 6.  Cytokine-Induced Senescence in the Tumor Microenvironment and Its Effects on Anti-Tumor Immune Responses.

Authors:  Maximilian Rentschler; Heidi Braumüller; Priscilla S Briquez; Thomas Wieder
Journal:  Cancers (Basel)       Date:  2022-03-08       Impact factor: 6.639

7.  CRISPR-Cas9-mediated induction of large chromosomal inversions in human bronchial epithelial cells.

Authors:  Andriani Angelopoulou; Angelos Papaspyropoulos; Argyris Papantonis; Vassilis G Gorgoulis
Journal:  STAR Protoc       Date:  2022-03-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.